|
1
|
Orbach D, Sarnacki S, Brisse HJ,
Gauthier-Villars M, Jarreau PH, Tsatsaris V, Baruchel A, Zerah M,
Seigneur E, Peuchmaur M and Doz F: Neonatal cancer. Lancet Oncol.
14:e609–e620. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Isaacs H Jr: Fetal and neonatal leukemia.
J Pediatr Hematol Oncol. 25:348–361. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gamis AS, Alonzo TA, Gerbing RB, Hilden
JM, Sorrell AD, Sharma M, Loew TW, Arceci RJ, Barnard D, Doyle J,
et al: Natural history of transient myeloproliferative disorder
clinically diagnosed in Down syndrome neonates: A report from the
children's oncology group study A2971. Blood. 118:6752–6759; quiz
6996. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vyas P and Crispino JD: Molecular insights
into Down syndrome-associated leukemia. Curr Opin Pediatr. 19:9–14.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bull MJ: Committee on Genetics: Health
supervision for children with Down syndrome. Pediatrics.
128:393–406. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsai MH, Hou JW, Yang CP, Yang PH, Chu SM,
Hsu JF, Chiang MC and Huang HR: Transient myeloproliferative
disorder and GATA1 mutation in neonates with and without Down
syndrome. Indian J Pediatr. 78:826–832. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schifferli A, Hitzler J, Bartholdi D,
Heinimann K, Hoeller S, Diesch T and Kühne T: Transient
myeloproliferative disorder in neonates without Down syndrome: Case
report and review. Eur J Haematol. 94:456–462. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Massey GV, Zipursky A, Chang MN, Doyle JJ,
Nasim S, Taub JW, Ravindranath Y, Dahl G and Weinstein HJ:
Children's Oncology Group (COG): A prospective study of the natural
history of transient leukemia (TL) in neonates with Down syndrome
(DS): children's oncology group (COG) study POG-9481. Blood.
107:4606–4613. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Klusmann JH, Creutzig U, Zimmermann M,
Dworzak M, Jorch N, Langebrake C, Pekrun A, Macakova-Reinhardt K
and Reinhardt D: Treatment and prognostic impact of transient
leukemia in neonates with Down syndrome. Blood. 111:2991–2998.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Apollonsky N, Shende A, Ouansafi I, Brody
J, Atlas M and Aygun B: Transient myeloproliferative disorder in
neonates with and without Down syndrome: A tale of 2 syndromes. J
Pediatr Hematol Oncol. 30:860–864. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sikand GS, Taysi K, Strandjord SE,
Griffith R and Vietti TJ: Trisomy 21 in bone marrow cells of a
patient with a prolonged preleukemic phase. Med Pediatr Oncol.
8:237–242. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chisté M, Vrotsos E, Zamora C and Martinez
A: Chronic lymphocytic leukemia/small lymphocytic lymphoma
involving the aortic valve. Ann Diagn Pathol. 17:295–297. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Karandikar NJ, Aquino DB, McKenna RW and
Kroft SH: Transient myeloproliferative disorder and acute myeloid
leukemia in Down syndrome. An immunophenotypic analysis. Am J Clin
Pathol. 116:204–210. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Simons A, Shaffer LG and Hastings RJ:
Cytogenetic Nomenclature: Changes in the ISCN 2013 Compared to the
2009 Edition. Cytogenet Genome Res. 141:1–6. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lum SH, Choong SS, Krishnan S, Mohamed Z
and Ariffin H: GATA1 mutations in a cohort of Malaysian children
with Down syndrome-associated myeloid disorder. Singapore Med J.
57:320–324. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wolfe LC, Weinstein HJ and Ferry JA: Case
records of the Massachusetts general hospital. Weekly
clinicopathological exercises. Case 19–200. A five-day-old girl
with leukocytosis and a worsening rash from birth. N Engl J Med.
348:2557–2566. 2003.PubMed/NCBI
|
|
17
|
Ohkawa T, Miyamoto S, Sugie M, Tomizawa D,
Imai K, Nagasawa M, Morio T, Mizutani S and Takagi M: Transient
abnormal myelopoiesis in non-Down syndrome neonate. Pediatr Int.
57:e14–e17. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mezei G, Sudan M, Izraeli S and Kheifets
L: Epidemiology of childhood leukemia in the presence and absence
of Down syndrome. Cancer Epidemiol. 38:479–489. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cabelof DC, Patel HV, Chen Q, van Remmen
H, Matherly LH, Ge Y and Taub JW: Mutational spectrum at GATA1
provides insights into mutagenesis and leukemogenesis in Down
syndrome. Blood. 114:2753–2763. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Homans AC, Verissimo AM and Vlacha V:
Transient abnormal myelopoiesis of infancy associated with trisomy
21. Am J Pediatr Hematol Oncol. 15:392–399. 1993.PubMed/NCBI
|
|
21
|
Ono R, Hasegawa D, Hirabayashi S, Kamiya
T, Yoshida K, Yonekawa S, Ogawa C, Hosoya R, Toki T, Terui K, et
al: Acute megakaryoblastic leukemia with acquired trisomy 21 and
GATA1 mutations in phenotypically normal children. Eur J Pediatr.
174:525–531. 2015. View Article : Google Scholar : PubMed/NCBI
|
